Business Context and Reporting Period
This Form 8-K filing by BioRestorative Therapies, Inc. (Nevada) was submitted on April 12, 2013. The report details corporate governance actions approved by the Board of Directors and stockholders regarding the company's capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate structural changes rather than financial performance.
Material Changes
- Reverse Stock Split: A 1-for-50 reverse split of issued and outstanding common stock was approved, effective at the opening of business on April 15, 2013.
- Authorized Shares Reduction: The number of authorized common shares was reduced from 1,500,000,000 to 100,000,000.
- Regulatory Filing: A Certificate of Change was filed with the Secretary of State of Nevada to effect these changes.
Guidance, Outlook, and Risks
The filing includes a press release (Exhibit 99.1) announcing the reverse split and share reduction. The company explicitly states that the information furnished is not intended to constitute a determination that the information is material or complete, nor is it an admission that investors should consider this information before making an investment decision. No specific financial guidance or operational outlook is provided in this text.
Investor Verification Checklist
- Verify the effective date of the 1-for-50 reverse split (April 15, 2013) and its impact on share count.
- Confirm the new authorized share cap of 100,000,000.
- Review the attached Press Release (Exhibit 99.1) for additional context on the rationale for the split.
- Check subsequent filings for updated financial statements reflecting the post-split capitalization.